Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD Dermatology Times Source link
Top 5 Articles of the Week: April 12-17 Dermatology Times Source link
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says CNBC Source link
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link